论文部分内容阅读
国家“九五”重点科技攻关项目“基因重组人胰岛素”日前在吉林省通化东宝药业股份有限公司研制成功，我国由此成为世界上第３个能够生产、销售基因重组人胰岛素的国家。通化东宝公司的科研人员根据９０年代最新的分子生物学理论，跨越了国外几十年的研制阶段，运用全新的...
National “Ninth Five-Year” key scientific and technological project “recombinant human insulin” Recently in Tonghua, Jilin Province Dongbao Pharmaceutical Co., Ltd. successfully developed our country thus become the world’s third to produce and sell genetically modified human insulin country. Tonghua Dongbao company researchers based on the latest 90 years of molecular biology theory, across several decades of foreign research and development stage, the use of new ...